|
|||||||
| "Asenapine (Saphris) is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19, 2007 merge with Organon International. Development of the drug, through Phase III trials, began while Organon was still a part of Akzo Nobel.[." Read more about Zyprexa | |||||||
Asenapine
3D
Molecular Structure using Jmol
|
|
To
Rotate Molecule
-->> To
Zoom-->> Jmol
Menu --->> To view Using Chime -- PDB Structure of Asenapine Molecule NOTE: YOU MUST HAVE CHIME INSTALLED |
|
